In addition to NB cells, we observed a positive correlation between SMAD9 and MYCN (or MYCNOS) expression in high-risk NB tumors and a much lower correlation in the NB cohorts that included fewer high-risk patients (Fig. 6C), consistent with previous results (Figs. 1D and S2E-G). Here, SMAD9 is linked to neuroblastoma.